- Home
- LENZ vs QSI Comparison
LENZ vs QSI Comparison
Compare LENZ & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LENZ | QSI |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 165.6M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LENZ | QSI |
|---|---|---|
| Price | $3.79 | $1.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $24.00 | $2.30 |
| AVG Volume (30 Days) | 666.8K | ★ 2.1M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $153.04 | $406.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.60 | $0.69 |
| 52 Week High | $49.85 | $3.10 |
Technical Indicators
Market Signals| Indicator | LENZ | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 33.95 | 78.88 |
| Support Level | $3.60 | $1.16 |
| Resistance Level | $6.11 | $1.33 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 23.38 | 90.82 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.